BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kogiso T, Egawa H, Teramukai S, Taniai M, Hashimoto E, Tokushige K, Sakisaka S, Sakabayashi S, Yamamoto M, Umeshita K, Uemoto S. Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study. Hepatol Commun 2017;1:394-405. [PMID: 29404468 DOI: 10.1002/hep4.1037] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Tanaka A. Challenges for diagnosis and treatment of primary biliary cholangitis. Translational Autoimmunity 2023. [DOI: 10.1016/b978-0-323-85389-7.00007-7] [Reference Citation Analysis]
2 Martin EF. Liver Transplantation for Primary Biliary Cholangitis. Clin Liver Dis 2022;26:765-81. [PMID: 36270728 DOI: 10.1016/j.cld.2022.06.014] [Reference Citation Analysis]
3 Iljinsky IM, Tsirulnikova OM. Liver transplantation for primary biliary cholangitis (review). RJTAO 2022;24:15-22. [DOI: 10.15825/1995-1191-2022-1-15-22] [Reference Citation Analysis]
4 Nakamura T, Shirouzu T. Antibody-Mediated Rejection and Recurrent Primary Disease: Two Main Obstacles in Abdominal Kidney, Liver, and Pancreas Transplants. J Clin Med 2021;10:5417. [PMID: 34830699 DOI: 10.3390/jcm10225417] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut 2021;70:1989-2003. [PMID: 34266966 DOI: 10.1136/gutjnl-2020-322362] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
6 Gao L, Wang L, Woo E, He X, Yang G, Bowlus C, Leung PSC, Gershwin ME. Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends. Clin Rev Allergy Immunol. 2019;. [PMID: 31713023 DOI: 10.1007/s12016-019-08772-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
7 Pedersen MR, Greenan G, Arora S, Murali AR, Mayo MJ. Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation: A Meta-Analysis. Liver Transpl 2021;27:866-75. [PMID: 33185320 DOI: 10.1002/lt.25935] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
8 Barba Bernal R, Medina-morales E, Goyes D, Patwardhan V, Bonder A. Management of Autoimmune Liver Diseases after Liver Transplantation. Transplantology 2021;2:162-82. [DOI: 10.3390/transplantology2020016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Iljinsky IM, Tsirulnikova OM. Primary biliary cholangitis. RJTAO 2021;23:162-170. [DOI: 10.15825/1995-1191-2021-1-162-170] [Reference Citation Analysis]
10 Li X, Peng J, Ouyang R, Yang Y, Yu C, Lin H. Risk factors for recurrent primary biliary cirrhosis after liver transplantation: A systematic review and meta-analysis. Dig Liver Dis 2021;53:309-17. [PMID: 33380381 DOI: 10.1016/j.dld.2020.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Tanaka A. Current understanding of primary biliary cholangitis. Clin Mol Hepatol 2021;27:1-21. [PMID: 33264835 DOI: 10.3350/cmh.2020.0028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
12 Chen C, Ke R, Yang F, Cai Q, Liu J, Huang X, Chen J, Xu F, Jiang Y. Risk factors for recurrent autoimmune liver diseases after liver transplantation: A meta-analysis. Medicine (Baltimore) 2020;99:e20205. [PMID: 32443344 DOI: 10.1097/MD.0000000000020205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Tanaka A, Leung PS, Gershwin ME. Recurrent Autoimmune Liver Disease and its Scientific Significance. Autoimmune Liver Disease 2020. [DOI: 10.1002/9781119532637.ch14] [Reference Citation Analysis]
14 Tanaka A, Leung PSC, Bowlus CL, Gershwin ME. Primary Biliary Cholangitis. Liver Immunology 2020. [DOI: 10.1007/978-3-030-51709-0_22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Tanaka A, Kono H, Leung PSC, Gershwin ME. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus. Cell Immunol 2020;347:104021. [PMID: 31767117 DOI: 10.1016/j.cellimm.2019.104021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
16 Kogiso T, Tokushige K. Key roles of hepatologists in successful liver transplantation. Hepatol Res 2018;48:608-21. [PMID: 29722107 DOI: 10.1111/hepr.13183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Montano-Loza AJ, Mason AL. Recurrence of primary biliary cholangitis after liver transplantation: A Japanese perspective. Hepatol Commun 2017;1:391-3. [PMID: 29404467 DOI: 10.1002/hep4.1058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]